CABB Group invests in growth and flexibility on the Gersthofen and Knapsack sites
Sulzbach (Taunus), Germany – The CABB Group plans to further build on its global position as a producer of ultrapure monochloroacetic acid. The company has earmarked an investment figure well into the double-digit million euros range for expanding its production and storage capacities by the end of 2019. Work will focus on the Gersthofen and Knapsack sites in Germany. CABB serves a broad spectrum of specialty chemicals customers, supplying monochloroacetic acid and derivatives from its sites in Germany and China.
"The goal of this investment program is to offer an even higher degree of flexibility and reliability to our customers worldwide," says Carsten W. Woerner, General Manager of Business Unit Acetyls.
Valerie Diele-Braun, who took over as CEO of the CABB Group at the end of August adds: "We want to continue to build on the extraordinarily positive trend seen at our Acetyls business unit and expand our strong global footprint. These extensive investments reaffirm our commitment to establish the right conditions for sustainable growth."
Categories
Chemical substances
Countries
Companies
Latest news
INEOS launches €250m investment supported by the French Government to secure the future of French industry at Lavera
The project marks the first phase of a long-term regeneration plan to reduce emissions, boost reliability, efficiency and competitiveness, with support of the French State.
Hycamite’s technology to decarbonize shipping awarded AiP by industry leader DNV
Kokkola Industrial Park →Hycamite’s proprietary Thermo-Catalytic Decomposition (TCD) technology offers a new approach to producing clean hydrogen by breaking down methane, the primary component of liquefied natural gas (LN...
Clariant catalysts will power the Ecoplanta: Europe's first waste-to-methanol plant
Chemmed Cluster Tarragona →Repsol is building Europe’s first plant to produce renewable methanol from urban waste The facility will use Enerkem gasification technology to produce 240 KTA of methanol Clariant will supply cata...
Lilly plans to build a new $3 billion facility to boost oral medicine manufacturing capacity in Europe for patients worldwide
Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain
